StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
ShareholdingNov 16, 2026, 06:48 AM

MESOBLAST LTD: Director Discloses Shareholding of 1,860 Ordinary Shares

AI Summary

MESOBLAST LTD filed a Form 6-K detailing director's relevant interests in securities. The filing indicates that a director holds 186 American Depositary Shares, representing 1,860 ordinary shares. These securities are held in the form of ADSs by custodian JP Morgan Nominees Australia Pty Limited. No other interests in contracts or registered holdings were disclosed.

Key Highlights

  • Director holds 186 American Depositary Shares representing 1,860 ordinary shares.
  • Shares are held in the form of American Depositary Shares (ADSs).
  • Custodian for the ADSs is JP Morgan Nominees Australia Pty Limited.